Bluejay Diagnostics (BJDX) Cash from Operations (2022 - 2023)
Historic Cash from Operations for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to -$2.8 million.
- Bluejay Diagnostics' Cash from Operations rose 566.41% to -$2.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$8.3 million, marking a year-over-year decrease of 739.22%. This contributed to the annual value of -$7.8 million for FY2024, which is 594.31% up from last year.
- According to the latest figures from Q4 2023, Bluejay Diagnostics' Cash from Operations is -$2.8 million, which was up 566.41% from -$1.1 million recorded in Q3 2023.
- In the past 5 years, Bluejay Diagnostics' Cash from Operations registered a high of -$1.1 million during Q3 2023, and its lowest value of -$2.9 million during Q4 2022.